Enzyme treatment
US6780628B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 8, 2000 |
| Grant date | Aug 24, 2004 |
| Priority date | — |
| Expiry date | Feb 4, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Enzymes of a particular class, characterized by the ability to cleave a linkage that effects release of a cell-surface protein or carbohydrate, which does not contain an anti-infection agent, display significant anti-infectious activity. Upon oral administration, these enzymes are effective, for example, in the treatment of digestive tract infections in humans and in animals. In the latter, there are benefits of significantly improved growth rate, feed efficiency, and overall health.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.